UniProt ID | CNOT3_HUMAN | |
---|---|---|
UniProt AC | O75175 | |
Protein Name | CCR4-NOT transcription complex subunit 3 | |
Gene Name | CNOT3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 753 | |
Subcellular Localization | Cytoplasm . Nucleus . Cytoplasm, P-body. NANOS2 promotes its localization to P-body.. | |
Protein Description | Component of the CCR4-NOT complex which is one of the major cellular mRNA deadenylases and is linked to various cellular processes including bulk mRNA degradation, miRNA-mediated repression, translational repression during translational initiation and general transcription regulation. Additional complex functions may be a consequence of its influence on mRNA expression. May be involved in metabolic regulation; may be involved in recruitment of the CCR4-NOT complex to deadenylation target mRNAs involved in energy metabolism. Involved in mitotic progression and regulation of the spindle assembly checkpoint by regulating the stability of MAD1L1 mRNA. Can repress transcription and may link the CCR4-NOT complex to transcriptional regulation; the repressive function may involve histone deacetylases. Involved in the maintenance of emryonic stem (ES) cell identity.. | |
Protein Sequence | MADKRKLQGEIDRCLKKVSEGVEQFEDIWQKLHNAANANQKEKYEADLKKEIKKLQRLRDQIKTWVASNEIKDKRQLIDNRKLIETQMERFKVVERETKTKAYSKEGLGLAQKVDPAQKEKEEVGQWLTNTIDTLNMQVDQFESEVESLSVQTRKKKGDKDKQDRIEGLKRHIEKHRYHVRMLETILRMLDNDSILVDAIRKIKDDVEYYVDSSQDPDFEENEFLYDDLDLEDIPQALVATSPPSHSHMEDEIFNQSSSTPTSTTSSSPIPPSPANCTTENSEDDKKRGRSTDSEVSQSPAKNGSKPVHSNQHPQSPAVPPTYPSGPPPAASALSTTPGNNGVPAPAAPPSALGPKASPAPSHNSGTPAPYAQAVAPPAPSGPSTTQPRPPSVQPSGGGGGGSGGGGSSSSSNSSAGGGAGKQNGATSYSSVVADSPAEVALSSSGGNNASSQALGPPSGPHNPPPSTSKEPSAAAPTGAGGVAPGSGNNSGGPSLLVPLPVNPPSSPTPSFSDAKAAGALLNGPPQFSTAPEIKAPEPLSSLKSMAERAAISSGIEDPVPTLHLTERDIILSSTSAPPASAQPPLQLSEVNIPLSLGVCPLGPVPLTKEQLYQQAMEEAAWHHMPHPSDSERIRQYLPRNPCPTPPYHHQMPPPHSDTVEFYQRLSTETLFFIFYYLEGTKAQYLAAKALKKQSWRFHTKYMMWFQRHEEPKTITDEFEQGTYIYFDYEKWGQRKKEGFTFEYRYLEDRDLQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
41 | Ubiquitination | NAANANQKEKYEADL HHHHHHHHHHHHHHH | 56.85 | - | |
82 | Ubiquitination | RQLIDNRKLIETQME HHHHHHHHHHHHHHH | 61.13 | - | |
98 | Phosphorylation | FKVVERETKTKAYSK HCEEECHHCCCCCCC | 50.68 | 22210691 | |
100 | Phosphorylation | VVERETKTKAYSKEG EEECHHCCCCCCCCC | 28.46 | 20068231 | |
103 | Phosphorylation | RETKTKAYSKEGLGL CHHCCCCCCCCCCCH | 23.10 | 20068231 | |
104 | Phosphorylation | ETKTKAYSKEGLGLA HHCCCCCCCCCCCHH | 29.14 | 20068231 | |
105 | Ubiquitination | TKTKAYSKEGLGLAQ HCCCCCCCCCCCHHH | 43.03 | - | |
113 | Acetylation | EGLGLAQKVDPAQKE CCCCHHHCCCHHHHH | 42.89 | 23236377 | |
131 | Phosphorylation | VGQWLTNTIDTLNMQ HHHHHHHHHHHHHHC | 18.26 | 22468782 | |
144 | Phosphorylation | MQVDQFESEVESLSV HCHHHHHHHHHHCCH | 48.51 | 22468782 | |
194 | Phosphorylation | LRMLDNDSILVDAIR HHHHCCCCHHHHHHH | 24.87 | 20230923 | |
241 | Phosphorylation | IPQALVATSPPSHSH CCHHHHHCCCCCCCC | 34.00 | 26074081 | |
242 | Phosphorylation | PQALVATSPPSHSHM CHHHHHCCCCCCCCC | 25.69 | 26074081 | |
245 | Phosphorylation | LVATSPPSHSHMEDE HHHCCCCCCCCCCCC | 40.79 | 26074081 | |
247 | Phosphorylation | ATSPPSHSHMEDEIF HCCCCCCCCCCCCCC | 28.94 | 26074081 | |
291 | Phosphorylation | DDKKRGRSTDSEVSQ HHHHCCCCCCHHHHC | 39.11 | 29255136 | |
292 | Phosphorylation | DKKRGRSTDSEVSQS HHHCCCCCCHHHHCC | 42.03 | 29255136 | |
294 | Phosphorylation | KRGRSTDSEVSQSPA HCCCCCCHHHHCCCC | 39.73 | 29255136 | |
297 | Phosphorylation | RSTDSEVSQSPAKNG CCCCHHHHCCCCCCC | 22.38 | 29255136 | |
299 | Phosphorylation | TDSEVSQSPAKNGSK CCHHHHCCCCCCCCC | 21.22 | 29255136 | |
335 | Phosphorylation | PPAASALSTTPGNNG CCCHHHCCCCCCCCC | 29.92 | 26074081 | |
336 | Phosphorylation | PAASALSTTPGNNGV CCHHHCCCCCCCCCC | 37.55 | 26074081 | |
337 | Phosphorylation | AASALSTTPGNNGVP CHHHCCCCCCCCCCC | 26.31 | 26074081 | |
351 | Phosphorylation | PAPAAPPSALGPKAS CCCCCCHHHCCCCCC | 34.76 | 26074081 | |
358 | Phosphorylation | SALGPKASPAPSHNS HHCCCCCCCCCCCCC | 27.93 | 26074081 | |
362 | Phosphorylation | PKASPAPSHNSGTPA CCCCCCCCCCCCCCC | 37.09 | 26074081 | |
365 | Phosphorylation | SPAPSHNSGTPAPYA CCCCCCCCCCCCCCC | 38.32 | 26074081 | |
367 | Phosphorylation | APSHNSGTPAPYAQA CCCCCCCCCCCCCCC | 18.99 | 26074081 | |
371 | Phosphorylation | NSGTPAPYAQAVAPP CCCCCCCCCCCCCCC | 17.29 | 26074081 | |
403 | Phosphorylation | SGGGGGGSGGGGSSS CCCCCCCCCCCCCCC | 37.22 | 22817900 | |
467 | Phosphorylation | GPHNPPPSTSKEPSA CCCCCCCCCCCCCCC | 51.60 | - | |
468 | Phosphorylation | PHNPPPSTSKEPSAA CCCCCCCCCCCCCCC | 49.98 | - | |
469 | Phosphorylation | HNPPPSTSKEPSAAA CCCCCCCCCCCCCCC | 39.08 | - | |
473 | Phosphorylation | PSTSKEPSAAAPTGA CCCCCCCCCCCCCCC | 31.47 | 27080861 | |
478 | Phosphorylation | EPSAAAPTGAGGVAP CCCCCCCCCCCCCCC | 34.63 | 20873877 | |
487 | Phosphorylation | AGGVAPGSGNNSGGP CCCCCCCCCCCCCCC | 36.97 | 27080861 | |
491 | Phosphorylation | APGSGNNSGGPSLLV CCCCCCCCCCCCEEE | 49.48 | 27080861 | |
495 | Phosphorylation | GNNSGGPSLLVPLPV CCCCCCCCEEEECCC | 37.30 | 20873877 | |
506 | Phosphorylation | PLPVNPPSSPTPSFS ECCCCCCCCCCCCHH | 50.65 | 30278072 | |
507 | Phosphorylation | LPVNPPSSPTPSFSD CCCCCCCCCCCCHHH | 38.27 | 30278072 | |
509 | Phosphorylation | VNPPSSPTPSFSDAK CCCCCCCCCCHHHHH | 33.25 | 30206219 | |
511 | Phosphorylation | PPSSPTPSFSDAKAA CCCCCCCCHHHHHHH | 39.60 | 30206219 | |
513 | Phosphorylation | SSPTPSFSDAKAAGA CCCCCCHHHHHHHHH | 40.78 | 30278072 | |
529 | Phosphorylation | LNGPPQFSTAPEIKA HCCCCCCCCCCCCCC | 20.57 | 20068231 | |
530 | Phosphorylation | NGPPQFSTAPEIKAP CCCCCCCCCCCCCCC | 47.74 | 20068231 | |
541 | Phosphorylation | IKAPEPLSSLKSMAE CCCCCCHHHHHHHHH | 44.32 | 26657352 | |
542 | Phosphorylation | KAPEPLSSLKSMAER CCCCCHHHHHHHHHH | 47.72 | 25159151 | |
554 | Phosphorylation | AERAAISSGIEDPVP HHHHHHHCCCCCCCC | 37.36 | 28555341 | |
635 | Methylation | PSDSERIRQYLPRNP CCHHHHHHHHCCCCC | 25.88 | 54557691 | |
645 | Phosphorylation | LPRNPCPTPPYHHQM CCCCCCCCCCCCCCC | 43.54 | - | |
685 | Phosphorylation | LEGTKAQYLAAKALK HHCHHHHHHHHHHHH | 11.81 | - | |
689 | Ubiquitination | KAQYLAAKALKKQSW HHHHHHHHHHHHCCH | 48.95 | - | |
714 | Phosphorylation | QRHEEPKTITDEFEQ HCCCCCCCCCHHHHC | 39.56 | 26846344 | |
716 | Phosphorylation | HEEPKTITDEFEQGT CCCCCCCCHHHHCCE | 34.41 | 26846344 | |
723 | Phosphorylation | TDEFEQGTYIYFDYE CHHHHCCEEEEECHH | 13.36 | 26846344 | |
724 | Phosphorylation | DEFEQGTYIYFDYEK HHHHCCEEEEECHHH | 10.64 | 26846344 | |
726 | Phosphorylation | FEQGTYIYFDYEKWG HHCCEEEEECHHHHC | 4.68 | 26846344 | |
729 | Phosphorylation | GTYIYFDYEKWGQRK CEEEEECHHHHCCCC | 14.98 | 26846344 | |
737 | Ubiquitination | EKWGQRKKEGFTFEY HHHCCCCCCCCEEEE | 66.32 | 21890473 | |
737 (in isoform 1) | Ubiquitination | - | 66.32 | 21890473 | |
741 | Phosphorylation | QRKKEGFTFEYRYLE CCCCCCCEEEEEEEC | 26.81 | 28509920 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CNOT3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CNOT3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CNOT3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CAND2_HUMAN | CAND2 | physical | 12207886 | |
CNOT8_HUMAN | CNOT8 | physical | 10637334 | |
CNOT9_HUMAN | RQCD1 | physical | 22939629 | |
HNRLL_HUMAN | HNRNPLL | physical | 22939629 | |
ID3_HUMAN | ID3 | physical | 18255255 | |
CNOT1_HUMAN | CNOT1 | physical | 26344197 | |
CNOT2_HUMAN | CNOT2 | physical | 26344197 | |
CNOT7_HUMAN | CNOT7 | physical | 26344197 | |
CNOT9_HUMAN | RQCD1 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-299, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-299, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-299, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-292, AND MASSSPECTROMETRY. |